Exclusive: Takeda to win EU approval for $62 billion Shire deal – sources

Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London’s Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday.


Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

5 × three =